Appointment booking for Dr. Joseph Piacentine, MD is currently not available.Dr. Joseph Piacentine, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Joseph Piacentine, MD (he/him) is a Pediatrician in Tempe, AZ with over 18 years of experience. What is your opinion of Dr. Joseph Piacentine, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Joseph Piacentine, MD has received over $1,300 which includes payments from the following companies:
$213.63 from Neos Therapeutics, LP
$134.07 from GlaxoSmithKline, LLC.
$122.12 from AbbVie, Inc.
$121.39 from Merck Sharp & Dohme Corporation
$115.43 from QIAGEN Sciences LLC
$107.86 from Cranial Technologies, Inc
$74.78 from Shire North American Group Inc
$51.97 from Takeda Pharmaceuticals U.S.A., Inc.
$44.60 from Kaleo, Inc.
$40.61 from Pfizer Inc.
$29.66 from Sanofi Pasteur Inc.
$25.88 from Mylan Specialty L.P.
$25.47 from Novo Nordisk Inc
$24.32 from Noven Pharmaceuticals, Inc.
$21.00 from Reckitt Benckiser LLC
$20.82 from Aerocrine, Inc
$15.93 from Ironshore Pharmaceuticals Inc.
$14.64 from Alcon Laboratories Inc
$13.77 from Mylan Pharmaceuticals Inc.
$13.52 from Genentech USA, Inc.
Payments received by Dr. Joseph Piacentine, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!